References
- SackRLAuckleyDAugerRRCircadian rhythm sleep disorders: part I, basic principles, shift work and jet lag disorders. An American Academy of Sleep Medicine reviewSleep200730111460148318041480
- National Sleep Foundation2008 Sleep in America PollWashington DCNational Sleep Foundation2008
- ThorpyMJLiebermanJA3rdRothTOwensGSPatient identificationAm J Manag Care200713Suppl 6S132S13918041874
- National Heart, Lung, and Blood Institute Working Group on InsomniaInsomnia: assessment and management in primary careAm Fam Physician199959113029303810392587
- NeubauerDNCurrent and new thinking in the management of comorbid insomniaAm J Manag Care200915SupplS24S3219298103
- SateiaMJUpdate on sleep and psychiatric disordersChest200913551370137919420207
- ParishJMSleep-related problems in common medical conditionsChest2009135256357219201722
- PilcherJJGinterDRSadowskyBSleep quality versus sleep quantity: relationships between sleep and measures of health, well-being and sleepiness in college studentsJ Psychosom Res19974265835969226606
- NewmanABSpiekermanCFEnrightPDaytime sleepiness predicts mortality and cardiovascular disease in older adults. The Cardiovascular Health Study Research GroupJ Am Geriatr Soc200048211512310682939
- ElwoodPHackMPickeringJHughesJGallacherJSleep disturbance, stroke, and heart disease events: evidence from the Caerphilly cohortJ Epidemiol Community Health2006601697316361457
- BixlerEOVigontzasANLinHMCalhounSLVela-BuenoAKalesAExcessive daytime sleepiness in a general population sample: the role of sleep apnea, age, obesity, diabetes, and depressionJ Clin Endocrinol Metab20059084510451515941867
- Ferini-StrambiLBaiettoCDi GiolaMRCognitive dysfunction in patients with obstructive sleep apnea (OSA): partial reversibility after positive airway pressure (CPAP)Brain Res Bull2003611879212788211
- DeanBAguilarDShapiroCImpaired health status, daily functioning, and work productivity in adults with excessive sleepinessJ Occup Environ Med20105214414920134351
- OmachiTAClamanDMBlancPDEisnerMDObstructive sleep apnea: a risk factor for work disabilitySleep200932679179819544756
- DrakeCLRoehrsTRichardsonGWalshJKRothTShift work sleep disorder: prevalence and consequences beyond that of symptomatic day workersSleep20042781453146215683134
- LegerDThe cost of sleep-related accidents: a report for the National Commission on Sleep Disorders ResearchSleep199417184937677805
- FlatleyDReynerLAHorneJASleep-related crashes on sections of different road types in the UK (1995–2001)LondonDepartment of Transport, Road Safety Research Report No 522004
- Pandi-PerumalSRVersterJCKayumovLSleep disorders, sleepiness and traffic safety: a public health menaceBraz J Med Biol Res200639786387116862276
- US Department of TransportationEffects of sleep schedules on commercial motor vehicle driver performance2000 Available from: http://www.fmcsa.dot.gov/documents/execsumm-e1.pdfAccessed Dec 22, 2009
- LopesCEstevesAMBittencourtLRATufikSMelloMTRelationship between the quality of life and the severity of obstructive sleep apnea syndromeBraz J Med Biol Res2008411090891318820762
- DodelRPeterHNoelkerCHealth-related quality of life in patients with narcolepsySleep Med200787–873374117512797
- OzakiAInoueYNakajimaTHealth-related quality of life among drug-naïve patients with narcolepsy with cataplexy, narcolepsy without cataplexy, and idiopathic hypersomnia without long sleep timeJ Clin Sleep Med20084657257819110887
- BaldwinCMGriffthKANietoFJO’ConnorGTWaslebenJARedlineSThe association of sleep-disordered breathing and sleep symptoms with quality of life in the Sleep Heart Health StudySleep2001249610511204058
- BrionesBAdamsNStraussMRelationship between sleepiness and general health statusSleep1996195835888899938
- ReimerMAFlemonsW WQuality of life in sleep disordersSleep Med Rev2003733534914505600
- SforzaEJanssensJ PRochatTIbanezVDeterminants of quality of life in patients with sleep-related breathing disordersEur Respir J200321468268712762357
- ChervinRDSleepiness, fatigue, tiredness, and lack of energy in obstructive sleep apneaChest2000118237237910936127
- JohnsM WA new method for measuring daytime sleepiness: the Epworth sleepiness scaleSleep19911465405451798888
- CarskadonMADementWCMitlerMMRothTWestbrookPRKeenanSGuidelines for the Multiple Sleep Latency Test (MSLT): a standard measure of sleepinessSleep198695195243809866
- LittnerMRKushidaCWiseMPractice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness testSleep20052811312115700727
- American Academy of Sleep MedicineInternational Classification of Sleep DisordersDiagnostic and Coding Manual2nd Ed.Westchester, ILAmerican Academy of Sleep Medicine2005
- YoungTPaltaMDempseyJSkatrudJWeberSBadrSThe occurrence of sleep-disordered breathing among middle-aged adultsN Engl J Med199332817123012358464434
- SmithIEQuinnellTGPharmacotherapies for obstructive sleep apnoea: where are we now? Drugs200464131385139915212557
- SullivanCEIssaFGBerthon-JonesMEvesLReversal of obstructive sleep apnoea by continuous positive airway pressure applied through the naresLancet1981182258628656112294
- WeaverTEMaislinGDingesDFRelationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioningSleep200730671171917580592
- MorgenthalerTIKapenSLee-ChiongTPractice parameters for the medical therapy of obstructive sleep apneaSleep20062981031103516944671
- BlackJEHirshkowitzMModafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndromeSleep200528446447116171291
- HirshkowitzMBlackJEWesnesKNieblerGAroraSRothTAdjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndromeRespir Med2007101361662716908126
- RothTWhiteDSchmidt-NowaraWEffects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adultsClin Ther200628568970616861091
- RothTRipponGAAroraSArmodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apneaSleep Breath2008121536217874255
- SchwartzJRHirshkowitzMErmanMKSchmidt-NowaraWModafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week open-label studyChest200312462192219914665500
- SchwartzJRRothTShift work sleep disorder: burden of illness and approaches to managementDrugs200666182357237017181377
- McMenaminTMA time to work: recent trends in shift work and fexible schedulesMonth Lab RevDec 2007:315 Available from: http://www.bls.gov/opub/mlr/2007/12/art1full.pdfAccessed Oct 15, 2009
- WaageSMoenBEPallesenSShift work disorder among oil rig workers in the North SeaSleep200932455856519413151
- CzeislerCAWalshJKRothTModafinil for excessive sleepiness associated with shift-work disorderN Engl J Med2005353547648616079371
- CzeislerCAWalshJKWesnesKAAroraSRothTArmodafinil for treatment of excessive sleepiness associated with shift work disorder: a randomized controlled studyMayo Clin Proc2009841195897219880686
- ErmanMKRosenbergRfor the US Modafinil Shift Work Sleep Disorder Study GroupModafinil for excessive sleepiness associated with chronic shift-work sleep disorder: effects on patient functioning and health-related quality of lifePrim Care Companion J Clin Psychiatry20079318819417632651
- HartCLHaneyMNasserJFoltinRWCombined effects of methamphetamine and zolpidem on performance and mood during simulated night shift workPharmacol Biochem Behav200581355956815936062
- LongstrethWTJrTonTGKoepsellTGersukVHHendricksonAVeldeSPrevalence of narcolepsy in King County, Washington, USASleep Med200910442242619013100
- WiseMSArandDLAugerRRBrooksSNWatsonNFfor the American Academy of Sleep MedicineTreatment of narcolepsy and other hypersomnias of central originSleep200730121712172718246981
- US Xyrem Multicenter Study GroupA randomized, double-blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsySleep2002251424911833860
- US Xyrem Multicenter Study GroupSodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsySleep Med20045211912315033130
- Xyrem International Study GroupA double-blind placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsyJ Clin Sleep Med20051439139717564408
- Xyrem International Study GroupFurther evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patientsSleep Med20056541542116099718
- HarshJRHaydakRRosenbergRThe efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsyCurr Med Res Opin200622476177416684437
- US Modafinil in Narcolepsy Multicenter Study GroupRandomized trial of modafinil for the treatment of pathological somnolence in narcolepsyAnn Neurol199843188979450772
- US Modafinil in Narcolepsy Multicenter Study GroupRandomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsyNeurology20005451166117510720292
- WongYNKingS PSimcoeDOpen-label, single-dose pharmacokinetic study of modafinil tablets: influence of age and gender in normal subjectsJ Clin Pharmacol199939328128810073328
- WongYNSimcoeDHartmanLNA double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteersJ Clin Pharmacol199939130409987698
- FerraroLFuxeKTanganelliSTomasiniMCRambertFAAntonelliTDifferential enhancement of dialysate serotonin levels in distinct brain regions of the rat by modafinil: possible relevance for wakefulness and depressionJ Neurosci Res200268110711211933055
- MitchellHABogenpohlJ WLilesLCBehavioral responses of dopamine beta-hydroxylase knockout mice to modafinil suggest a dual noradrenergic – dopaminergic mechanism of actionPharmacol Biochem Behav200891221722218703079
- QuWMHuangZLXuXHMatsumotoNUradeYDopaminergic D1 and D2 receptors are essential for the arousal effect of modafinilJ Neurosci200828348462846918716204
- Food and Drug AdministrationFDA-approved Labeling Text for NDA 21-875/NUVIGIL™ (armodafinil) Tablets2007 June 15 Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021875lbl.pdfAccessed Oct 15, 2009
- RaoYLiuZ WBorokEProlonged wakefulness induces experience-dependent synaptic plasticity in mouse hypocretin/orexin neuronsJ Clin Invest2007117124022403318060037
- BeckPOdleAWallace-HuittTSkinnerRDGarcia-RillEModafinil increases arousal determined by P13 potential amplitude: an effect blocked by gap junction antagonistsSleep200831121647165419090320
- DarwishMKirbyMHellriegelETRobertsonPJrArmodafinil and modafinil have substantially different pharmacokinetic profiles despite having the same terminal half lives: analysis of data from three randomized, single-dose, pharmacokinetic studiesClin Drug Investig2009299613623
- DarwishMKirbyMHellriegelETYangRRobertsonPJrPharmacokinetic profile of armodafinil in healthy subjects: pooled analysis of data from three randomized studiesClin Drug Investig200929287100
- DarwishMKirbyMRobertsonPJrHellriegelETInteraction profile of armodafinil with medications metabolized by cytochrome P450 enzymes 1A2, 3A4 and 2C19 in healthy subjectsClin Pharmacokinet2008471617418076219
- WisorJ PDementWCAimoneLWilliamsMBozyczko-CoyneDArmodafinil, the R-enantiomer of modafinil: wake-promoting effects and pharmacokinetic profile in the ratPharmacol Biochem Behav200685349249917134745
- DingesDFAroraSDarwishMNieblerGEPharmacodynamic effects on alertness of single doses of armodafinil in healthy subjects during a nocturnal period of acute sleep lossCurr Med Res Opin200622115916716393442
- BlackJHullSGTillerJYangRHarshJRMaintenance of efficacy, safety and tolerability of armodafinil: an open-label extension studySleep200932SupplA139 [Abstract No. 0419]
- SchwartzJRKhanAMcCallVWeintraubJTillerJA 12-month or more open-label study of the efficacy and tolerability of armodafinilSleep200932SupplA50A51 [Abstract No. 0148]
- SchwartzJRBeckerPMTillerJBoganRKArmodafinil improves patient-reported outcomes in patients with excessive sleepiness associated with obstructive sleep apnea or narcolepsySleep200932SupplA190 [Abstract No. 0580]
- KrystalAHarshJYangRRipponGLankfordAA randomised, double-blind, placebo-controlled study with armodafinil in patients with residual excessive sleepiness associated with CPAP-treated obstructive sleep apnoea and comorbid depressive disordersPoster presented at the 19th Meeting of the European Neurological Society2009 June 20–24Milan, Italy [Abstract No. P353]
- AkerstedtTGillbergMSubjective and objective sleepiness in the active individualInt J Neurosci1990521–229372265922
- HullSLankfordAVinceBNieblerGEAroraSArmodafinil improves fatigue in patients with excessive sleepiness due to obstructive sleep apnea/hypopnea syndromePoster presented at the American Psychiatric Association Annual Meeting2006 May 25Toronto, Canada [Abstract No. 127]
- RussoMPharmacotherapy of excessive sleepiness: focus on armodafinilClin Med Ther20091415432
- BoganRTillerJYangRYouakimJRothTArmodafinil for excessive sleepiness associated with jet lag disorderSleep200932SupplA52 [Abstract No. 0153]